Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Endocyte Inc.
DescriptionSmall molecule drug conjugate consisting of a prostate-specific membrane antigen (PSMA; FOLH1; GCPII) targeting ligand linked to tubulysin B hydrazide (TubBH)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat recurrent metastatic castration-resistant prostate cancer (mCRPC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today